作者: Xiaojun Liang , Jie Shen
DOI: 10.1080/1120009X.2019.1692282
关键词:
摘要: The impact of KRAS mutation status on outcomes metastatic colorectal cancer (mCRC) treated with anti-angiogenic agents is controversial. A total 4,066 mCRC patients from nine randomized contr...